NL-OMON23804
Recruiting
Not Applicable
A pharmacokinetic study to assess age-related and intra-patient differences in the pharmacokinetics of intravenous pegylated liposomal doxorubicin in female cancer patients.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- pharmacokinetics
- Sponsor
- Erasmus University Medical Center
- Enrollment
- 34
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
/A
Investigators
Eligibility Criteria
Inclusion Criteria
- •2\. Solid tumour;
Exclusion Criteria
- •1\. Evidence of metastases in the central nervous system, unless previously treated and being asymptomatic/controlled for at least 3 months;
- •2\. History of cardiac disease, with NYHA Class II or greater, or clinical evidence of congestive heart failure or myocardial infarction within less than six months;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
A Study of Lasmiditan in Healthy ParticipantsHealthyNCT03182920Eli Lilly and Company35
Terminated
Phase 1
AGE Levels in ER+ Metastatic Breast Cancer Patients Receiving Endocrine TherapyBreast CancerNCT03092635Medical University of South Carolina9
Completed
Phase 1
A Pharmacokinetics Study of MultiHance in Pediatric PatientsCentral Nervous System PathologyNCT00411931Bracco Diagnostics, Inc15
Completed
Phase 2
The Pharmacokinetics of Anagrelide in Elderly and Young Patients With Essential Thrombocythaemia (ET)Essential ThrombocythaemiaNCT00413634Shire24
Terminated
Phase 1
Effect of Age-gender on the Pharmacokinetic and Pharmacodynamic Profiles of BIA 5 1058Pulmonary Arterial HypertensionNCT04991194Bial - Portela C S.A.61